Young James Emmett bought TLSI
February 5, 2025 · Form 4 insider transaction
Young James Emmett bought 6,000 shares of TriSalus Life Sciences, Inc. at $5.65 per share, a transaction worth $33.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
6,000
Price
$5.65
Total value
$33.9K
InsiderYoung James Emmett
RoleOfficer
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateFebruary 5, 2025
Filing dateFebruary 6, 2025
Shares owned after30,000
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person is the sole trustee of Kathleen A. Young Living Trust.